A randomized,open-label study of conjugated equine estrogens plus medroxyprogesterone acetate versus tibolone: effects on symptom control, bleeding pattern, lipid profile and tolerability

By Baracat E. C.   Barbosa I. C.   Giordano M. G.   Haidar M. A.   Marinho R. M.   Menegocci J. C.   Morais K. M.   Tomaz G.   Wehba S.  

Climacteric, Vol. 5, Iss. 1, 2002-03 ,pp. : 60-69

Informa Healthcare

Access to resources Recommend Favorite

Effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate on plasma lipids and lipoproteins, coagulation factors, and carbohydrate metabolism

By Lobo R.A.   Bush T.   Carr B.R.   Pickar J.H.  

Fertility and Sterility, Vol. 76, Iss. 1, 2001-07 ,pp. : 13-24

Elsevier

Access to resources Recommend Favorite

Endometrial effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate

By Pickar J.H.   Yeh I.-T.   Wheeler J.E.   Cunnane M.F.   Speroff L.  

Fertility and Sterility, Vol. 76, Iss. 1, 2001-07 ,pp. : 25-31

Elsevier

Access to resources Recommend Favorite

Effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate on endometrial bleeding

By Archer D.F.   Dorin M.   Lewis V.   Schneider D.L.   Pickar J.H.  

Fertility and Sterility, Vol. 75, Iss. 6, 2001-06 ,pp. : 1080-1087

Elsevier

Access to resources Recommend Favorite

Relief of vasomotor symptoms and vaginal atrophy with lower doses of conjugated equine estrogens and medroxyprogesterone acetate

By Utian W.H.   Shoupe D.   Bachmann G.   Pinkerton J.V.   Pickar J.H.  

Fertility and Sterility, Vol. 75, Iss. 6, 2001-06 ,pp. : 1065-1079

Elsevier

Access to resources Recommend Favorite